Hospital & Healthcare

Johnson & Johnson Medtech Partners with Qure.ai to Boost Early Detection of Lung Cancer in India 

This partnership embodies Johnson & Johnson MedTech's commitment to delivering life-saving innovations to healthcare providers...

New Femme Med and Spa Launches in Fort Wayne with Advanced Fat Reduction and Skin Tightening Technology

Innovative treatments now available to address fat loss, skin tightening, and incontinence without surgery...

OrthoLazer Highlights Drug-Free Pain Relief During Arthritis Awareness Month

Innovative Laser Therapy Offers Non-Invasive Treatment Alternative for Millions Living with Arthritis in the U.S....

Applied Medical Launches RHAPSO™ and GEMINI® to Advance Minimally Invasive Surgery

New suture passing instruments designed to enhance efficiency and precision in laparoscopic and robotic procedures...

Mucopolysaccharidosis Type I Market Projected for Steady Growth

DelveInsight forecasts an 8% CAGR from 2025 to 2034, driven by improved diagnostics and expanding treatment options....

Europe Embraces Health Data Sharing as Johnson & Johnson MedTech Survey Shows Rising Trust in Tech-Driven Care

Survey reveals strong public and professional confidence in digital health technologies to drive personalized treatment, surgical precision, and medical training across Europe....

Dawn Health and Merck Launch Advanced Digital Platform for Growth Disorder Management

Next-generation ecosystem enhances treatment adherence, remote monitoring, and personalized support for patients with growth hormone disorders....

Accuray Marks Milestone with First CyberKnife® SRS/SBRT Treatments in Austria

Innovative radiosurgery system debuts at Ordensklinikum Linz, advancing precision cancer care in the region ...

Implantica Expands RefluxStop™ Access with New Center of Excellence in Spain

Hospital Universitario Central de Asturias joins European network to offer innovative acid reflux implant as Implantica scales treatment reach across the region. ...

Aptamer Group and Neuro-Bio Adapt Saliva-Based Alzheimer’s Test to ELISA Format, Advancing Towards Commercialisation

The partnership aims to deliver a non-invasive, hospital-compatible diagnostic using Aptamer’s Optimer binders and Neuro-Bio’s novel early-stage biomarker, with commercial rollout targeted within 12–18 months....